penfluridol has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ashraf-Uz-Zaman, M; Cucullo, L; German, NA; Mikelis, CM; Sajib, MS | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chen, L; Hussain, Z; Li, S; She, P; Wu, Y; Zeng, X; Zhou, L | 1 |
| Ranjan, A; Srivastava, SK; Wright, S | 1 |
| Ranjan, A; Srivastava, SK | 1 |
| Hedrick, E; Li, X; Safe, S | 1 |
6 other study(ies) available for penfluridol and Disease Models, Animal
| Article | Year |
|---|---|
Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.
Topics: Animals; Antineoplastic Agents; Antipsychotic Agents; Cell Line, Tumor; Cell Survival; Central Nervous System; Disease Models, Animal; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Penfluridol; Protein Binding; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2018 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Drug Repositioning; Enterococcus faecalis; Erythrocytes; Female; Gram-Positive Bacterial Infections; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Microbial Viability; Opportunistic Infections; Penfluridol; Peritonitis | 2021 |
Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Glioblastoma; Humans; Immunomodulation; Macrophages; Mice; Myeloid-Derived Suppressor Cells; Penfluridol; Spleen; T-Lymphocytes, Regulatory; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |
Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Chloroquine; Disease Models, Animal; Drug Therapy, Combination; Heterografts; Mice; Neoplasm Transplantation; Pancreatic Neoplasms; Penfluridol; Treatment Outcome | 2016 |
Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Integrins; MicroRNAs; Nuclear Receptor Subfamily 4, Group A, Member 1; Penfluridol; Protein Binding; Reactive Oxygen Species; Signal Transduction; Sp Transcription Factors; Xenograft Model Antitumor Assays; Zinc Fingers | 2017 |